Sanofi India Ltd - 500674 - Shareholding for the Period Ended June 30, 2020
Sanofi India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here20-07-2020
20-07-2020
Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed copies of the Notice of the Board Meeting of the Company published today, in newspapers, Business Standard and Sakal.16-07-2020
Sanofi India Ltd - 500674 - Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Girish TekchandaniDesignation :- Company Secretary and Compliance Officer15-07-2020
Sanofi India Ltd - 500674 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The details of securities dematerialized during the quarter ended 30th June 2020, has been submitted by Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company to the stock exchanges where the shares of the Company are listed as per the requirements prescribed under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. A certificate confirming the said compliance received from our RTA is enclosed for your reference.15-07-2020
Sanofi India Ltd - 500674 - Board Meeting Intimation for Meeting Of Board Of Directors To Be Held On 28Th July 2020
Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company will be held on Tuesday, 28th July 2020; inter alia to consider the unaudited financial results for the quarter and half year ended 30th June 2020 (Q2)15-07-2020
Sanofi India Ltd - 500674 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Sanofi India Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here08-07-2020
Sanofi India Ltd - 500674 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed a summary of proceedings of the 64th Annual General Meeting of the Company held on 7th July 2020 through video conferencing facility. We are also enclosing a copy of the Scrutinizer's Report issued by M/s. Makarand M Joshi & Co., Company Secretaries on the remote e-voting conducted from 4th July 2020 to 6th July 2020 and e-voting at the Annual General Meeting held on 7th July 2020.08-07-2020
Sanofi, Regeneron stop late-stage US trial on Kevzara for Covid -19
However, an independent Sanofi trial on patients outside the US will continue06-07-2020
Glaxo, Sanofi near 500 mn pound UK vaccine deal
Money would be paid in stages as the vaccine progresses, with final payment made on delivery.05-07-2020
Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s), details of which are attached.02-07-2020